Quick Answer
Outlook Therapeutics, Inc. reported Total Assets of $18.58 million for fiscal year 2025.
Outlook Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $18.58M | -35.5% |
| 2024 | $28.82M | -10.8% |
| 2023 | $32.30M | +13.2% |
| 2022 | $28.53M | +25.1% |
| 2021 | $22.81M | +15.6% |
| 2020 | $19.73M | +15.2% |
| 2019 | $17.13M | -23.1% |
| 2018 | $22.28M | +7.5% |
| 2017 | $20.73M | -18.4% |
| 2016 | $25.41M | -27.4% |
| 2015 | $35.01M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $18.24M | +7.2% | -1.9% |
| September 30, 2025 | $18.58M | -35.5% | -17.0% |
| June 30, 2025 | $22.39M | -52.5% | +17.4% |
| March 31, 2025 | $19.08M | -67.7% | +12.2% |
| December 31, 2024 | $17.01M | -21.6% | -41.0% |
| September 30, 2024 | $28.82M | -10.8% | -38.8% |
| June 30, 2024 | $47.09M | +5.9% | -20.2% |
| March 31, 2024 | $59.03M | +9.3% | +172.2% |
- Outlook Therapeutics, Inc. showed a decrease of -35.5% in Total Assets compared to the prior fiscal year.
- Over the 2015–2025 period, Outlook Therapeutics, Inc.’s total assets has declined by 46.9% (from $35.01 million to $18.58 million).
- The most recent figure is from Outlook Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on December 19, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: